Dr. Po-Lin Hsu, who completed double doctoral degrees at the University of Cambridge and RWTH Aachen University, founded a leading-edge China-based medical device company, magAssist in 2017. Within three years, magAssist completed the development of the first class-III high technology barrier active product, the extracorporeal ventricular assist device from scratch. MoyoAssist Extra-VAD has now been applied in various clinical settings and has saved many patients. Meanwhile, we have launched the product lines of Percutaneous Ventricular Assist Device, portable ECMO, and Organ Care System, all of which are in the pre-clinical development stage.
“Insanity and Inventiveness of Innovators” - Fortune China